Search

Search Results
Results 1011 - 1020 of 1077 for Diabetes Type II
  • Abisart HCTZ
    Drug - 27 Mar 2023
    Consumer Medicine Information (CMI) about Abisart HCTZ intended for persons living in Australia.
  • Iptam Migraine Relief
    Drug - 9 Mar 2023
    Consumer Medicine Information (CMI) about Iptam Migraine Relief intended for persons living in Australia.
  • Duoplidogrel
    Drug - 7 Feb 2023
    Consumer Medicine Information (CMI) about Duoplidogrel intended for persons living in Australia.
  • DuoCover
    Drug - 7 Feb 2023
    Consumer Medicine Information (CMI) about DuoCover intended for persons living in Australia.
  • CoPlavix
    Drug - 7 Feb 2023
    Consumer Medicine Information (CMI) about CoPlavix intended for persons living in Australia.
  • Clopidogrel Winthrop Plus Aspirin
    Drug - 7 Feb 2023
    Consumer Medicine Information (CMI) about Clopidogrel Winthrop Plus Aspirin intended for persons living in Australia.
  • APX-Clopidogrel/Aspirin 75/100
    Drug - 7 Feb 2023
    Consumer Medicine Information (CMI) about APX-Clopidogrel/Aspirin 75/100 intended for persons living in Australia.
  • Vitreous Detachment
    Health - 30 Dec 2022
    The vitreous body is a round body of gel-like substance which fills the posterior chamber of the eye and aids in keeping the eyeball round. Within the gel are numerous fine strands which run to the...
  • Co-Diovan
    Drug - 1 Nov 2022
    Consumer Medicine Information (CMI) about Co-Diovan (Valsartan/hydrochlorothiazide) intended for persons living in Australia.
  • Iptam
    Drug - 26 Oct 2022
    Consumer Medicine Information (CMI) about Iptam (sumatriptan) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback